Martin C. Michel is a physician trained in experimental and clinical pharmacology in Essen (Germany) and San Diego (California). He headed the Nephrology and Hypertension Research Laboratory in Essen (1993-2002) and the Department of Pharmacology & Pharmacotherapy at the University of Amsterdam (The Netherlands, 2003-2011). Since 2011, he is the Global Head of Product and Pipeline Scientific Support at Boehringer Ingelheim and Professor of Pharmacology at the Johannes Gutenberg University in Mainz (Germany). He has published more than 400 scientific articles in peer reviewed journals that have been cited more than 19,000 times.
He is the Editor-in-Chief of Naunyn-Schmiedeberg’s Archives of Pharmacology and also serves on the board of many pharmacological, physiological and urological journals. His research focusses on urogenital and cardiovascular pharmacology.